Nice | Gatroesophageal Reflux Disease (GORD) in Children

25th May 2015 by Louise Hudman

Nice | Gatroesophageal Reflux Disease (GORD) in Children

This is a new guideline from Nice on the management of GORD in infants and children.

The main differences from common practice is that they advice that PPI or H2 antagonists are only used if other specific symptoms are present too (see below). Most children with isolated GORD need no treatment.

GORD in infants

Reassure parents that gastroesophageal reflux is a normal process. GORD (where it causes symptoms) is present in 40% of infants. Most therefore need no treatment and just reassurance that it will get better with time.

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"I must tell you that you have a brilliant team. I find it so convenient to ask for help and it's always tailored to my needs. Thanks a bunch :)"

Dr Aamina Khan

See the full list of features within our NASGP membership plans

Membership